An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network

Canadian Journal on Aging

Volumn 36, Issue 1, 2017, Pages 97-107

  Tannenbaum, Cara ^a   Farrell, Barbara ^b   Shaw, James ^c   Morgan, Steve ^d   Trimble, Johanna ^e   Currie, Jane ^d   Turner, Justin ^f   Rochon, Paula ^c   Silvius, James ^g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b BRUYÈRE RESEARCH INSTITUTE   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Canadian Patient Safety Institute   (Canada)

^f CENTRE DE RECHERCHE   (Canada)

^g ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Aging; deprescribing; health policy; inappropriate medications; patient engagement

Indexed keywords

ADVERSE DRUG REACTION; AGED; CANADA; COOPERATION; DEPRESCRIPTION; ECONOMICS; FEMALE; HEALTH CARE POLICY; HUMAN; MALE; POLYPHARMACY; PROCEDURES; PROGRAM DEVELOPMENT;

AGED; CANADA; COOPERATIVE BEHAVIOR; DEPRESCRIPTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEALTH CARE REFORM; HUMANS; MALE; POLYPHARMACY; PROGRAM DEVELOPMENT;

EID: 85009770763     PISSN: 07149808     EISSN: 17101107     Source Type: Journal    
DOI: 10.1017/S0714980816000702     Document Type: Article

References (66)

1. Agranoff, R., & McGuire, M. (2001). Big questions in public network management research. Journal of Public Administration Research and Theory, 11(3), 295-326.
2. Anderson, K., Stowasser, D., Freeman, C., & Scott, I. (2014). Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open, 4(12). e006544.
3. Berdot, S., Bertrand, M., Dartigues, J.-F., Fourrier, A., Tavernier, B., Ritchie, K., & Alperovitch, A. (2009). Inappropriate medication use and risk of falls-A prospective study in a large community-dwelling elderly cohort. BMC Geriatrics, 9(1). doi: 10.1186/1471-2318-9-30
4. Bergkvist, A., Midlov, P., Hoglund, P., Larsson, L., & Eriksson, T. (2009). A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. Journal of Evaluation in Clinical Practice, 15(4), 660-667.
5. Bess, K. D., Speer, P. W., & Perkins, D. D. (2012). Ecological contexts in the development of coalitions for youth violence prevention: An organizational network analysis. Health Education & Behavior, 39(5), 526-537.
6. Best, A., Greenhalgh, T., Lewis, S., Saul, J. E., Carroll, S., & Bitz, J. (2012). Large-system transformation in health care: A realist review. Milbank Quarterly, 90(3), 421-456.
7. Bierman, A. S., Pugh, M. J. V., Dhalla, I., Amuan, M., Fincke, G., Rosen, A., & Berlowitz, D. R. (2007). Sex differences in inappropriate prescribing among elderly veterans. The American Journal of Geriatric Pharmacotherapy, 5(2), 147-161.
8. Boulin, M., Diaby, V., & Tannenbaum, C. (2016). Preventing unnecessary costs of drug-induced hypoglycemia in older adults with type 2 diabetes in the United States and Canada. PLoS One, 11(9). e0162951.
9. Budnitz, D. S., Lovegrove, M. C., Shehab, N., & Richards, C. L. (2011). Emergency hospitalizations for adverse drug events in older Americans. New England Journal of Medicine, 365(21), 2002-2012.
10. Canadian Medical Association. (2015). A policyframework to guide a national seniors strategy. Retrieved from https://www. cma.ca/Assets/assets-library/document/en/about-us/gc2015/policy-framework-to-guide-seniors-en.pdf
11. Chaudoir, S. R., Dugan, A. G., & Barr, C. H. (2013). Measuring factors affecting implementation of health innovations: A systematic review of structural, organizational, provider, patient, and innovation level measures. Implementation Science, 6(1). doi: 10.1186/1748-5908-8-22
12. Chen, Y.-C., & Kreling, D. H. (2014). The effect of the Medicare part D benzodiazepine exclusion on the utilization patterns of benzodiazepines and substitute medications. Research in Social and Administrative Pharmacy, 10(2), 438-447.
13. Cheng, A. Y., & Lau, D. C. (2013). The Canadian Diabetes Association 2013 clinical practice guidelines-Raising the bar and setting higher standards! Canadian Journal of Diabetes, 37(3), 137-138.
14. Canadian Institutes of Health Research (CIHR). (2015). CIHR national stakeholder council meeting on safe medication management for older men and women across Canada. Retrieved from http://www.cihr-irsc.gc.ca/e/49001.html
15. Canadian Institutes of Health Research (CIHR). (2016). Second annual stakeholder meeting on safe medication management for older men and women across Canada. Retrieved from http://www.cihr-irsc.gc.ca/e/49690.html
16. Colla, C. H. (2014). Swimming against the current-What might work to reduce low-value care? New England Journal of Medicine, 371(14), 1280-1283.
17. Conklin, J., Farrell, B., Ward, N., McCarthy, L., Irving, H., & Raman-Wilms, L. (2015). Developmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: Protocol for a multiple case study. Implementation Science, 10(1). doi: 10.1186/s13012-015-0279-0
18. Cryer, P. E. (2008). The barrier of hypoglycemia in diabetes. Diabetes, 57(12), 3169-3176.
19. Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science, 4, 50. doi: 10.1186/1748-5908-4-50
20. de Gage, S. B., Bégaud, B., Bazin, F., Verdoux, H., Dartigues, J.-F., Pérès, K.,.. Pariente, A. (2012). Benzodiazepine use and risk of dementia: Prospective population based study. British Medical Journal, 345. http://dx.doi.org/10.1136/bmj.e6231
21. Farrell, B., Tsang, C., Raman-Wilms, L., Irving, H., Conklin, J., & Pottie, K. (2015). What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: A modified delphi process. PLoS One, 10(4). e0122246
22. Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. British Medical Journal, 331(7526). http://dx.doi.org/10.1136/bmj.38623.768588.47
23. Gnjidic, D., Le Couteur, D. G., Kouladjian, L., & Hilmer, S. N. (2012). Deprescribing trials: Methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clinics in GeriatricMedicine, 28(2), 237-253.
24. Gomm, W., von Holt, K., Thomé, F., Broich, K., Maier, W., Fink, A.,. & Haenisch, B. (2016). Association of proton pump inhibitors with risk of dementia: A pharmaco-epidemiological claims data analysis. JAMA Neurology, 73(4), 410-416.
25. Hohl, C. M., Nosyk, B., Kuramoto, L., Zed, P. J., Brubacher, J. R., Abu-Laban, R. B.,.. & Sobolev, B. (2011). Outcomes of emergency department patients presenting with adverse drug events. Annals of Emergency Medicine, 58(3), 270-279. doi: 10.1186/1472-6963-13-473
26. Holmes, H. M., Min, L. C., Yee, M., Varadhan, R., Basran, J., Dale, W., & Boyd, C. M. (2013). Rationalizing prescribing for older patients with multimorbidity: Considering time to benefit. Drugs & Aging, 30(9), 655-666.
27. Howlett, J. G., Chan, M., Ezekowitz, J. A., Harkness, K., Heckman, G. A., Kouz, S.,.. & Abrams, H. (2016). The Canadian cardiovascular society heart failure companion: Bridging guidelines to your practice. Canadian Journal of Cardiology, 32(3), 296-310.
28. Iyer, S., Naganathan, V., McLachlan, A. J., & Le Conteur, D. G. (2008). Medication withdrawal trials in people aged 65 years and older. Drugs & Aging, 25(12), 1021-1031.
29. Jafari, B., & Britton, M. E. (2015). Hypoglycaemia in elderly patients with type 2 diabetes mellitus: A review of risk factors, consequences and prevention. Journal of Pharmacy Practice and Research, 45(4), 459-469.
30. Jansen, J., Naganathan, V., Carter, S. M., McLachlan, A., Nickel, B., Irwig, L.,.. & Turner, R. (2016). Too much medicine in older people? Deprescribing through shared decision making. British Medical Journal, 353, i2893.
31. Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009). Interventions that can reduce inappropriate prescribing in the elderly. Drugs & Aging, 26(12), 1013-1028.
32. Kenis, P., & Provan, K. G. (2009). An exogenous theory of public network performance. Public Administration, 87, 440-456.
33. Kotter, J. P. (1996). Why transformation efforts fail. The Journal of Product Innovation Management, 2(13). https://cb.hbsp. harvard.edu/resources/marketing/docs/95204f2.pdf
34. Lang, P O., Vogt-Ferrier, N., Hasso, Y., Le Saint, L., Drame, M., Zekry, D.,.. & Prudent, M. (2012). Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: Interventional study in 150 acutely ill elderly patients with mental and somatic comorbid conditions. Journal of the American Medical Directors Association, 13(4), 406. http://dx.doi.org/10.1016/j.jamda.2011.03.008
35. Marcum, Z. A., Amuan, M. E., Hanlon, J. T., Aspinall, S. L., Handler, S. M., Ruby, C. M., & Pugh, M. J. V. (2012). Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. Journal of the American Geriatrics Society, 60(1), 34-41.
36. Michie, S., van Stralen, M. M., & West, R. (2011). The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implementation Science, 6(1), 42.
37. Morgan, S. G., Hunt, J., Rioux, J., Proulx, J., Weymann, D., & Tannenbaum, C. (2016). Frequency and cost of potentially inappropriate prescribing for older adults: A cross-sectional study. CMAJ Open, 4(2). doi: 10.9778/cmajo.20150131
38. Mudge, A., Radnedge, K., Kasper, K., Mullins, R., Adsett, J., Rofail, S.,.. & Barras, M. (2016). Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Australian Health Review, 40(1), 86-91.
39. Muscedere, J., Andrew, M. K., Bagshaw, S. M., Estabrooks, C., Hogan, D., Holroyd-Leduc, J.,.. & McNally, M. (2016). Screening for frailty in Canada's health care system: A time for action. Canadian Journal on Aging/La Revue canadienne du vieillissement, 35(3), 1-17.
40. Nilsen, P., Stahl, C., Roback, K., & Cairney, P (2013). Never the twain shall meet?-A comparison of implementation science and policy implementation research. Implementation Science, 8(1). doi: 10.1186/178-5908-8-63
41. Niven, D. J., Mrklas, K. J., Holodinsky, J. K., Straus, S. E., Hemmelgarn, B. R., Jeffs, L. P., & Stelfox, H. T. (2015). Towards understanding the de-adoption of low-value clinical practices: A scoping review. BMC Medicine, 13(1). doi: 10.1186/s12916-015-0488-z
42. O'Mahony, D., O'Sullivan, D., Byrne, S., O'Connor, M. N., Ryan, C., & Gallagher, P (2014). STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age and Ageing, 44(2), 213-218. doi: 10.1093/ageing/afu145
43. Opondo, D., Eslami, S., Visscher, S., De Rooij, S. E., Verheij, R., Korevaar, J. C., & Abu-Hanna, A. (2012). Inappropriateness of medication prescriptions to elderly patients in the primary care setting: A systematic review. PLoS One, 7(8). e43617.
44. Proulx, J., & Hunt, J. (2014). Drug use among seniors on public drug programs in Canada, 2012. Healthcare Quarterly (Toronto, Ont.), 18(1), 11-13.
45. Provan, K. G., & Kenis, P (2008). Modes of network governance: Structure, management, and effectiveness. Journal of Public Administration Research and Theory, 18(2), 229-252.
46. Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D. (2013). Patient barriers to and enablers of deprescribing: A systematic review. Drugs & Aging, 30(10), 793-807.
47. Reeve, E., & Wiese, M. D. (2014). Benefits of deprescribing on patients' adherence to medications. International Journal of Clinical Pharmacy, 36(1), 26-29.
48. Richard, L., Barthélémy, L., Tremblay, M., Pin, S., & Gauvin, L. (2013). Interventions de prévention et promotion de la santé pour les aînés: modèle écologique. Guide d'aide à l'action francoquébécois. Saint-Denis: Inpes, coll. Santé en action.
49. Rochon, P. A., Gruneir, A., Gill, S. S., Wu, W., Fischer, H. D., Bronskill, S. E.,.. & Bell, C. M. (2013). Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy. Journal of the American Geriatrics Society, 61(1), 55-61.
50. Rochon, P A., & Gurwitz, J. H. (1997). Optimising drug treatment for elderly people: The prescribing cascade. BMJ: British Medical Journal, 315(7115), 1096-1099.
51. Schaffer, A. L., Buckley, N. A., Cairns, R., & Pearson, S.A. (2016). Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: Taking control of prescription drug use. JAMA Internal Medicine, 176(8), 1223-1225.
52. Schoenfeld, A. J., & Grady, D. (2016). Adverse effects associated with proton pump inhibitors. JAMA Internal Medicine, 176(2), 172-174.
53. Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D.,.. & Page, A. (2015). Reducing inappropriate polypharmacy: The process of deprescribing. JAMA Internal Medicine, 175(5), 827-834.
54. Sera, L. C., & McPherson, M. L. (2012). Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clinics in Geriatric Medicine, 28(2), 273-286.
55. Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007). Appropriate prescribing in elderly people: How well can it be measured and optimised? The Lancet, 370(9582), 173-184.
56. Stockl, K. M., Le, L., Zhang, S., & Harada, A. (2010). Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. The American Journal of Managed Care, 16(1), el-10.
57. Tannenbaum, C., Diaby, V., Singh, D., Perreault, S., Luc, M., & Vasiliadis, H.-M. (2015). Sedative-hypnotic medicines and falls in community-dwelling older adults: A cost-effectiveness (decision-tree) analysis from a US Medicare perspective. Drugs & Aging, 32(4), 305-314.
58. Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014). Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Internal Medicine, 174(6), 890-898.
59. Thompson, W., & Farrell, B. (2013). Deprescribing: What is it and what does the evidence tell us? The Canadian Journal of Hospital Pharmacy, 66(3), 201-202.
60. Todd, A., & Holmes, H. M. (2015). Recommendations to support deprescribing medications late in life. International Journal of Clinical Pharmacy, 37(5), 678-681.
61. Trivedi, D., Goodman, C., Gage, H., Baron, N., Scheibl, F., Iliffe, S.,.. & Drennan, V. (2013). The effectiveness of inter-professional working for older people living in the community: A systematic review. Health and Social Care in the Community, 21(2), 113-128.
62. Turner, J. P., Edwards, S., Stanners, M., Shakib, S., & Bell, J. S. (2016). What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open, 6(3). e009781.
63. Woodward, M. C. (2003). Deprescribing: Achieving better health outcomes for older people through reducing medications. Journal ofPharmacy Practice and Research, 33(4), 323-328.
64. Wu, C., Bell, C. M., & Wodchis, W. P. (2012). Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments. Drug Safety, 35(9), 769-781.
65. Ysa, T., Sierra, V., & Esteve, M. (2014). Determinants of network outcomes: The impact of management strategies. Public Administration, 92(3), 636-655.
66. Zed, P. J., Abu-Laban, R. B., Balen, R. M., Loewen, P. S., Hohl, M., Brubacher, J. R.,. & Lacaria, K. (2008). Incidence, severity and preventability of medication-related visits to the emergency department: A prospective study. Canadian Medical Association Journal, 178(12), 1563-1569.